InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

CapsoVision, Inc

CV Clue Score55
United States Fiscal year ends December CIK 0001378325
$6.59 -0.45% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.59 +41.87% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 2 Jul 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue11.8Operating income−19.9Net income−19.9EPS, diluted−9.85Fiscal year 2025Revenue13.6 +15.3%Operating income−25.5Net income−25.3EPS, diluted−1.03
FY2024FY2025
Revenue 11.8 13.6
Growth +15.3%
Operating income −19.9 −25.5
Net income −19.9 −25.3
Growth
EPS, diluted −9.85 −1.03

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2024Gross margin54.2%Operating margin−169.4%Net margin−169.3%Free cash flow margin−172.2%Fiscal year 2025Gross margin52.9%Operating margin−188.3%Net margin−186.8%Free cash flow margin−169.4%
FY2024FY2025
Gross margin 54.2% 52.9%
Operating margin −169.4% −188.3%
Net margin −169.3% −186.8%
Free cash flow margin −172.2% −169.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow−20.1Capital expenditure−0.2Free cash flow−20.2Fiscal year 2025Operating cash flow−22.9Capital expenditure−0.1Free cash flow−23.0
FY2024FY2025
Operating cash flow −20.1 −22.9
Capital expenditure −0.2 −0.1
Free cash flow −20.2 −23.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
FY2024FY2025
Shareholders’ equity −129.5 13.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
54.2% 52.9%
−169.4% −188.3%
−169.2% −186.6%
−169.3% −186.8%
−172.2% −169.4%
Spending
128.6% 135.1%
35.8% 50.5%
1.3% 0.7%
Returns
n/a −190.9%
−118.4% −139.4%
Balance and payout
16.0% 27.0%